Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limitedverified

T14.SI

Price:

$3.33

Market Cap:

$27.01B

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceut...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2000-01-03

Stock Exchange

SES

Ticker

T14.SI

The ROE as of December 2025 (TTM) for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) is 42.27%

According to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited’s latest financial reports and current stock price. The company's current ROE is 42.27%. This represents a change of 294.10% compared to the average of 10.73% of the last 4 quarters.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) Historical ROE (quarterly & annually)

How has T14.SI ROE performed in the past?

The mean historical ROE of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited over the last ten years is 13.55%. The current 42.27% ROE has changed 212.06% with respect to the historical average. Over the past ten years (40 quarters), T14.SI's ROE was at its highest in in the December 2024 quarter at 18.17%. The ROE was at its lowest in in the December 2021 quarter at 1.69%.

Quarterly (TTM)
Annual

Average

13.55%

Median

11.56%

Minimum

10.23%

Maximum

28.42%

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) ROE by Quarter and Year

Discovering the peaks and valleys of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 90.13%

Maximum Annual ROE = 28.42%

Minimum Annual Increase = -11.11%

Minimum Annual ROE = 10.23%

Quarterly (TTM)
Annual
YearROEChange
202428.42%90.13%
202314.95%13.12%
202213.21%9.35%
202112.08%6.08%
202011.39%-1.88%
201911.61%1.84%
201811.40%7.20%
201710.63%3.93%
201610.23%-11.11%
201511.51%-11.08%

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) Average ROE

How has T14.SI ROE performed in the past?

The current ROE of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

18.86%

5-year avg

16.01%

10-year avg

13.55%

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) ROE vs. Peers

How is T14.SI’s ROE compared to its peers?

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited’s ROE is greater than Yanlord Land Group Limited (-8.18%), less than Haw Par Corporation Limited (6.08%), less than China Aviation Oil (Singapore) Corporation Ltd (8.59%), less than Valuetronics Holdings Limited (11.86%), less than Q & M Dental Group (Singapore) Limited (8.32%),

Build a custom stock screener for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's ROE?

How is the ROE calculated for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

What is the highest ROE for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

What is the 3-year average ROE for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

What is the 5-year average ROE for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)?

How does the current ROE for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI) compare to its historical average?